ADRO - Aduro BioTech, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
16,383
15,087
17,239
50,681
72,979
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
72,979
Operating Expenses
Research Development
69,529
75,836
89,382
87,718
58,649
Selling General and Administrative
34,859
36,035
33,751
34,277
27,805
Total Operating Expenses
104,946
112,455
123,692
122,544
86,543
Operating Income or Loss
-88,563
-97,368
-106,453
-71,863
-13,564
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-9,101
-4,056
-218
-40
-26,238
Income Before Tax
-91,938
-96,140
-103,227
-69,684
-39,308
Income Tax Expense
-2,661
-783
-11,364
21,464
-99
Income from Continuing Operations
-89,277
-95,357
-91,863
-91,148
-39,209
Net Income
-89,277
-95,357
-91,863
-91,148
-39,209
Net Income available to common shareholders
-89,277
-95,357
-91,863
-91,148
-39,209
Reported EPS
Basic
-
-1.21
-1.26
-1.40
-0.88
Diluted
-
-1.21
-1.26
-1.40
-0.88
Weighted average shares outstanding
Basic
-
78,812
72,901
65,201
44,706
Diluted
-
78,812
72,901
65,201
44,706
EBITDA
-
-92,415
-102,468
-69,311
-12,841